For the first time, Pfizer has shared early data for their much-anticipated children's COVID-19 vaccine. The vaccine was studied in kids ages five to eleven. Doctor Frank Esper is an infectious disease specialist with Cleveland Clinic Children's. He says the children's vaccine is a lower dose than what's given to adults, but appears just as effective.